Back

Safety and effectiveness of tegoprazan in patients treated with dual antiplatelet therapy after drug-eluting stent implantation for acute myocardial infarction.

31 August 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Pharmacotherapy in acute coronary syndromes (4) Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Oh-Hyun Lee

Yongin Severance Hospital, Yongin (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Aspirin does not reduce cardiovascular risk in smokers across coronary calcium scores after coronary computed tomography angiography
Mr G. Winther (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Safety and efficacy of clopidogrel reloading in patients on chronic clopidogrel therapy presenting with ACS - a systematic review and meta-analysis
Doctor B. Hakkeem (Kozhikode, IN)
Abstract Slides Video
Presentation thumbnail
Impact of beta-blocker nebivolol versus carvedilol prescription at discharge on long-term clinical outcomes in STEMI patients with reduced LVEF treated with drug-eluting stents
Professor S. Park (Seoul, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Pharmacotherapy in acute coronary syndromes (4)

The Event

Event poster

ESC Congress 2025

31 August 2025 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Proton pump inhibitors in myocardial infarction: safety paradox in Type 1 vs. Type 2---a multicenter retrospective cohort study
thumbnail
Congress Presentation
Association between reduced risk of gastrointestinal bleeding related to proton pump inhibitor use and subsequent all-cause death in patients with percutaneous coronary intervention
thumbnail
Congress Session
Antiplatelet therapy: novel approaches for acute coronary syndrome and percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources